Preoperative Window of Opportunity Study With Giredestrant (GDC-9545) or Tamoxifen in Premenopausal Women With ER[+]/HER2[-] & Ki67 ≥10% Early Breast Cancer

Conditions:   Breast Cancer;   Breast Cancer, Early-Onset Interventions:   Drug: Giredestrant;   Drug: Tamoxifen Sponsor:   MedSIR Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials